The global Assisted Reproductive Technology Device market is experiencing rapid growth due to increasing infertility rates, rising maternal age, and expanding fertility clinic infrastructure. The market was valued at USD 3.2 billion in 2023 and increased to USD 3.5 billion in 2024, representing year-over-year growth of 9.3%. Analysts project the assisted reproductive technology device market will reach USD 6.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2032.

Globally, infertility affects approximately 15% of reproductive-age couples, equivalent to nearly 186 million individuals. Over 2.8 million assisted reproductive technology cycles are performed annually worldwide, creating increasing demand for specialized assisted reproductive technology device systems used in fertility treatment and embryo handling.

Historical Market Performance (2015–2024)

The assisted reproductive technology device industry has expanded steadily over the past decade due to growing demand for fertility treatments. In 2015, the global assisted reproductive technology device market was valued at approximately USD 1.8 billion.

By 2017, the market reached USD 2.1 billion, representing 16.7% growth in two years. Continued technological advancements and rising fertility clinic expansion pushed the market to USD 2.6 billion in 2019, reflecting a 23.8% increase compared to 2017.

During the pandemic period, fertility treatment demand temporarily declined but recovered quickly. The assisted reproductive technology device market grew from USD 2.7 billion in 2020 to USD 3.0 billion in 2022, representing 11.1% cumulative growth.

Between 2015 and 2024, the assisted reproductive technology device market expanded by nearly 94%, demonstrating strong long-term growth.

Year-Over-Year Growth Trends

The assisted reproductive technology device market continues to demonstrate consistent annual growth supported by increasing fertility procedures worldwide.

• 2021: USD 2.8 billion

• 2022: USD 3.0 billion (7.1% YoY growth)

• 2023: USD 3.2 billion (6.7% YoY growth)

• 2024: USD 3.5 billion (9.3% YoY growth)

Market expansion is expected to accelerate further as fertility clinics increase capacity. Forecasts suggest the assisted reproductive technology device market could reach USD 3.8 billion in 2025 and USD 4.2 billion in 2026, reflecting annual growth rates between 8% and 10%.

Rising Infertility Rates Driving Market Demand

Infertility remains a major global health concern. According to global health surveys, 1 in 6 couples worldwide experience fertility challenges, increasing demand for assisted reproductive treatments.

The number of fertility clinics worldwide increased from 3,200 clinics in 2015 to nearly 4,900 clinics in 2024, representing 53% growth over nine years. Each clinic relies heavily on advanced assisted reproductive technology device equipment such as incubators, cryopreservation systems, micromanipulators, and imaging technologies.

Government initiatives are also supporting fertility treatments. In 2023, fertility support programs received over USD 1.2 billion in public healthcare funding globally, helping expand access to assisted reproductive services.

Device Type and Technology Segmentation

The assisted reproductive technology device market includes several specialized technologies essential for laboratory fertilization procedures.

Incubators represent the largest segment, accounting for 28% of assisted reproductive technology device revenue in 2024, valued at approximately USD 980 million. These systems maintain controlled environments necessary for embryo development.

Other major device segments include:

• Micromanipulators: 19% market share

• Cryosystems: 17% share

• Sperm separation devices: 14% share

• Imaging systems: 12% share

• Laser systems and other devices: 10% share

Advanced time-lapse embryo imaging systems are gaining popularity. Adoption of these technologies increased by 37% between 2020 and 2024, as clinics seek higher embryo selection accuracy.

Fertility Procedure Statistics and Treatment Volumes

The number of assisted reproductive technology procedures continues to rise globally. In 2015, approximately 2.1 million ART cycles were performed worldwide. By 2020, this number increased to 2.5 million cycles, representing 19% growth in five years.

In 2024, annual ART procedures reached approximately 2.8 million cycles, with projections indicating more than 3.5 million cycles annually by 2030.

The in vitro fertilization (IVF) procedure dominates ART treatments, accounting for 72% of total procedures globally. Intracytoplasmic sperm injection (ICSI) represents 24% of procedures, while other ART techniques account for 4%.

Each IVF cycle requires multiple assisted reproductive technology device systems, including incubation chambers, cryogenic storage tanks, and laboratory imaging platforms.

Regional Market Insights and Revenue Distribution

North America leads the assisted reproductive technology device market, accounting for 38% of global revenue in 2024, equivalent to approximately USD 1.33 billion. The region benefits from advanced fertility clinics and high treatment adoption rates.

Europe represents 30% of the market, generating nearly USD 1.05 billion in revenue. Countries such as Spain, Germany, and the United Kingdom are major ART treatment hubs, performing over 1.1 million fertility cycles annually.

Asia-Pacific is the fastest-growing regional market, holding 23% share in 2024 and expected to grow at a CAGR of 11.2% through 2032. China, India, Japan, and South Korea are witnessing increasing fertility clinic investments.

The Middle East and Latin America collectively account for 9% of global assisted reproductive technology device demand, supported by expanding private fertility treatment facilities.

Industry Investments and Corporate Developments

The assisted reproductive technology device industry is witnessing strong investment activity. Global fertility technology companies invested approximately USD 780 million in research and development during 2023, representing 13% growth compared to 2021.

Manufacturing capacity for assisted reproductive technology device equipment increased by 21% between 2020 and 2024, driven by rising demand from fertility clinics.

Private equity investments in fertility care infrastructure exceeded USD 4.5 billion globally between 2021 and 2024, funding the construction of new clinics and acquisition of advanced ART laboratory equipment.

Additionally, medical technology companies are focusing on AI-driven embryo selection technologies that can improve implantation success rates by 15–20%.

Future Market Forecast (2025–2032)

The assisted reproductive technology device market is expected to maintain strong growth momentum through the next decade. Forecast projections indicate:

• 2025: USD 3.8 billion

• 2026: USD 4.2 billion

• 2028: USD 5.0 billion

• 2030: USD 5.9 billion

• 2032: USD 6.8 billion

Fertility clinic expansion will remain a key growth driver. By 2032, the global number of fertility clinics is expected to exceed 6,500 facilities, increasing demand for assisted reproductive technology device equipment.

Emerging technologies such as AI-based embryo selection, automated cryopreservation systems, and smart incubation chambers are expected to significantly improve clinical outcomes and accelerate market growth.

Conclusion: Strong Growth Outlook for Assisted Reproductive Technology Device Market

The assisted reproductive technology device market is experiencing strong growth due to increasing infertility prevalence, expanding fertility clinics, and rapid technological innovation. The market has grown from USD 1.8 billion in 2015 to USD 3.5 billion in 2024, representing substantial long-term expansion.

With a projected CAGR of 9.4%, the assisted reproductive technology device market is expected to reach USD 6.8 billion by 2032. Rising fertility procedures, increasing healthcare funding, and continuous innovation in embryo incubation and cryopreservation technologies will continue to drive market demand worldwide.

Read Full Research Study: Assisted Reproductive Technology Device Market
https://marketintelo.com/report/assisted-reproductive-technology-device-market